United Kingdom: MHRA Issues Guidance for Clinical Trials Impacted by COVID-19
March 18, 2020
On March 12, 2020, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) issued Advice for Management of Clinical Trials in relation to Coronavirus that provides information related to protocol deviation, sites, and participant safety.
